🔎 Trials Near Me

Akèy › Kansè Selil Plazmatik › New York

Etid klinik pou Kansè Selil Plazmatik nan New York

6 etid pou Kansè Selil Plazmatik ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

  • Mount Sinai, The Tisch Cancer Instutute, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT04879043

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
  • North Shore University Hospital, Manhasset
  • Long Island Jewish Medical Center, New Hyde Park
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06152575

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

  • Memorial Sloan-Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT05651932

Delayed Toxicities Post-CAR-T

  • Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07665307

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activities), New York
  • ak 1 plis
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT07052916

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

  • University of Rochester, Rochester
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2025 · NCT05597345

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.